Evidence map›Paper›PMID 42446417›Full record

Observational studyActa dermato-venereologica2026

Chronic Pruritus in Predialysis Chronic Kidney Disease: Prevalence, Phenotype and Temporal Patterns in a Prospective Cohort.

Severin Schricker, Thomas Mettang, Frank Strutz, Thorsten Rittweiler, Moritz Schanz, Leonie Kraft, Jörg Latus, Julian Müller-Kühnle

Abstract readObservational Study
In one paragraph

Observational study in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Severin SchrickerDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany. severin.schricker@rbk.de.ORCID 0000-0002-6770-3056
Thomas MettangKidney Center Wiesbaden, Wiesbaden, Germany.ORCID 0000-0001-5749-0184
Frank StrutzKidney Center Wiesbaden, Wiesbaden, Germany.
Thorsten RittweilerDialysis Center Friedrichroda, Friedrichroda, Germany.
Moritz SchanzDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.
Leonie KraftDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.ORCID 0000-0002-5821-893X
Jörg LatusDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.ORCID 0000-0003-0584-4870
Julian Müller-KühnleDepartment of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany; Paracelsus Medical University, Nuremberg, Germany.ORCID 0009-0005-8849-5101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CKD-associated pruritus (CKD-aP) is a burden some symptom with incompletely understood pathophysiology and limited predialysis data. In this prospective observational study, 95 adult nondialysis CKD patients (stages G1-G5) were followed for up to 36 months (232 observations), 86 patients were analysed after exclusion of chronic dermatological conditions. Chronic pruritus (≥6 weeks) was assessed using a numerical rating scale (NRS) and anatomical mapping. Chronic pruritus occurred in 26 of 86 patients (30.2%), with numerically higher prevalence in advanced CKD (G3b-5 : 32.8% vs G1-3a: 22.7%), whereas intensity was numerically higher in early CKD (median 8 vs 5). The back, legs and head/ face were most frequently affected, consistent with the bilateral, nondermatomal pattern described in dialysis populations. Among patients with repeated assessments, 19.0% showed an episodic trajectory and 7.6% had persistent pruritus. Multivariable logistic regression and generalized estimating equations (GEE) were used to identify independent predictors of chronic pruritus. No laboratory parameter, including PTH, was independently associated with pruritus. Dyslipidaemia was the only clinical characteristic significantly associated with pruritus status (69.2% vs 43.3%, p=0.035). Given the modest sample size, smaller effect estimates may have been missed. CKD-aP affects approximately 1 in 3 predialysis patients, follows an episodic course, and is not explained by any single biochemical marker, supporting multifactorial pathophysiology.

Indexed as

PruritusRenal Insufficiency, ChronicAdultAgedChronic DiseaseDyslipidemiasFemaleHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisPhenotypePrevalenceProspective StudiesRisk Factors

Identifiers

PMID42446417
PMCPMC13366731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.